Abstract
MicroRNA (abbr. miRNA) is an endogenous small non-coding RNAs (containing ~22 nucleotides) found in plants and animals, which functions in transcriptional and post-transcriptional regulation of gene expression. These endogenous gene expression inhibitors were primarily described in cancer but recent emerging roles in the regulation of autoimmune inflammation which is thought to be associated with cardiovascular diseases (CVDs), including atherosclerosis known as an autoimmune disease. MiRNA controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ, and plays the roles in endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophages, and thereby leading to regulate the progression of atherosclerosis. MiRNA modulates several pathways such as lipid uptake and Toll-like receptor (TLR) signaling, implicating an involvement in plaque development. In the present review, we focus on the roles of microRNAs in atherosclerosis through which highlight the therapeutic possibility for the treatment of atherosclerosis.
Keywords: Atherosclerosis, autoantibodies, MicroRNA, Toll-like receptor and inflammatory.
Current Medicinal Chemistry
Title:The Roles of MicroRNAs in Atherosclerosis
Volume: 21 Issue: 13
Author(s): Xinjie Lu and Vijay Kakkar
Affiliation:
Keywords: Atherosclerosis, autoantibodies, MicroRNA, Toll-like receptor and inflammatory.
Abstract: MicroRNA (abbr. miRNA) is an endogenous small non-coding RNAs (containing ~22 nucleotides) found in plants and animals, which functions in transcriptional and post-transcriptional regulation of gene expression. These endogenous gene expression inhibitors were primarily described in cancer but recent emerging roles in the regulation of autoimmune inflammation which is thought to be associated with cardiovascular diseases (CVDs), including atherosclerosis known as an autoimmune disease. MiRNA controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ, and plays the roles in endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophages, and thereby leading to regulate the progression of atherosclerosis. MiRNA modulates several pathways such as lipid uptake and Toll-like receptor (TLR) signaling, implicating an involvement in plaque development. In the present review, we focus on the roles of microRNAs in atherosclerosis through which highlight the therapeutic possibility for the treatment of atherosclerosis.
Export Options
About this article
Cite this article as:
Lu Xinjie and Kakkar Vijay, The Roles of MicroRNAs in Atherosclerosis, Current Medicinal Chemistry 2014; 21 (13) . https://dx.doi.org/10.2174/0929867321666131218100606
DOI https://dx.doi.org/10.2174/0929867321666131218100606 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autophagy: A Major Target of Cadmium Nephrotoxicity
Current Chemical Biology Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Current Pharmaceutical Design Mitochondria Damage in the Pathogenesis of Diabetic Retinopathy and in the Metabolic Memory Associated with its Continued Progression
Current Medicinal Chemistry New Developments in Anthracycline-Induced Cardiotoxicity
Current Medicinal Chemistry Determination of Stimulants and Diuretics in Dietary Supplements for Weight Loss and Physical Fitness by Ion-pair Chromatography and Pulsed Amperometric Detection (PAD)
Current Analytical Chemistry Tracking the Mesenchymal Stem Cell Fate After Transplantation Into the Infarcted Myocardium
Current Stem Cell Research & Therapy Hydrogels: A Journey from Diapers to Gene Delivery
Mini-Reviews in Medicinal Chemistry Comparison of Uptake Mechanisms for Anthracyclines in Human Leukemic Cells
Current Drug Delivery Energy Metabolism in the Normal and in the Diabetic Heart
Current Pharmaceutical Design Cardiovascular Disease in Patients with Diabetic Nephropathy
Current Molecular Medicine Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
Current Medicinal Chemistry Water Soluble Vitamins and their Role in Diabetes and its Complications
Current Diabetes Reviews Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
Vascular Disease Prevention (Discontinued) Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Current Topics in Medicinal Chemistry Developments in Imaging Technologies Related to Hypertensive Cardiovascular Diseases
Current Pharmaceutical Design Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism The Medicinal Chemistry of Genus <i>Aralia</i>
Current Topics in Medicinal Chemistry Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Current Pharmaceutical Design Cardiovascular Effects of EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibodies
Cardiovascular & Hematological Agents in Medicinal Chemistry